Skip to main content

Table 2 Univariable cox regression analysis for outcomes in the HCM cohort

From: Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy

Characteristics

Primary end point (n = 33)

Secondary end point (n = 43)

Unadjusted hazard ratio

p value

Unadjusted hazard ratio

p value

Age

1.026 (0.999, 1.054)

.055

1.016 (0.994, 1.038)

.156

Unexplained syncope

0.044 (0.001, 15.026)

.294

1.918 (0.809, 4.548)

.139

NSVT

0.518 (0.071, 3.805)

.518

1.551 (0.553, 4.347)

.404

SCD family history

0.636 (0.152, 2.664)

.535

0.937 (0.335, 2.622)

.901

LA diameter

1.004 (0.999, 1.008)

.088

1.005 (1.002, 1.009)

.002

Maximal LVWT

0.936 (0.861, 1.016)

.114

0.968 (0.906, 1.035)

.344

LVOT gradient pressure

0.980 (0.950, 1.011)

.200

0.994 (0.970, 1.019)

.653

Maximal LVWT ≥ 30 mm

0.048 (0.001, 652.152)

.531

0.833 (0.115, 6.053)

.857

LGE

1.107 (1.074, 1.142)

 < .001

1.116 (1.089, 1.144)

 < .001

LV wall entropy

1.356 (1.258, 1.463)

 < .001

1.356 (1.276, 1.441)

 < .001